logo-loader
RNS
Victrex PLC

Victrex PLC - Directorate Change

RNS Number : 2091H
Victrex PLC
05 April 2022
 

 

 

April 5, 2022                 

Victrex plc

Directorate change

Victrex appoints Ian Melling of Smith & Nephew plc as Chief Financial Officer

Ian to succeed Richard Armitage as CFO

Victrex plc is an innovative world leader in high performance polymer solutions, delivering sustainable products which support CO2 reduction and bring environmental and societal benefit in multiple end-markets. The Group is pleased to announce that Ian Melling has been appointed as Chief Financial Officer (CFO) and as an Executive Director of the Board, to succeed Richard Armitage.

As previously communicated, Richard will step down as CFO and from the Board on 27th May 2022. Ian will join Victrex and the Board on 4th July 2022.  The appointment follows a diverse and thorough search process. In the intervening period, Mike Ward, Finance Director, who has been with Victrex for nine years, will assume the role of interim CFO.

Career history:

Ian Melling, FCA, is a Chartered Accountant and currently Senior Vice-President, Corporate Finance and R&D for Smith & Nephew plc, the medical technology company, having served as Interim Chief Financial Officer during 2020.  Ian has served in a number of senior finance roles in the UK and internationally for Smith & Nephew, including those with divisional and functional responsibility, having joined the Group in 2006.  He served as Senior Vice-President Group Finance for five years until October 2021, prior to his current role.

 

His other roles have included Vice-President Finance for Spine & Biologics in the USA. Prior to joining Smith & Nephew plc, Ian was an Audit Manager for Deloitte in London. He holds a first class Masters degree in Chemistry from Oxford University.

 

Commenting on the appointment:

Dame Vivienne Cox, Chair of Victrex, said: "The Board is delighted that Ian has agreed to join Victrex. He is a commercially focused CFO, with listed company experience and a wealth of knowledge from an innovative global growth business. His background in Medical will also be beneficial for Victrex, as this is an end-market where we hold significant value and where we expect to see good growth over the years ahead. The Board would like to thank Richard for his contribution to Victrex and we look forward to welcoming Ian in due course."

 

Jakob Sigurdsson, Chief Executive of Victrex, said: "We are all looking forward to Ian joining Victrex as we continue to deliver on our Polymer & Parts strategy, with a strong and growing core business supported by our potentially game-changing mega-programmes. Our growth opportunities continue to build and Ian's experience will support us across Industrial and also in Medical, which we anticipate will become a larger part of the Group in the future."

 

There is no further information to be disclosed under Listing Rule 9.6.13

 

Notes:

1/ Ian will be appointed on a base salary of £350,000.

 

Enquiries:

Victrex plc:

Andrew Hanson, Director of Investor Relations & Corporate Communications        +44 (0) 1253 898121

                                                                                                                         +44 (0) 7809 595831

 

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy & Industrial, Electronics and Medical. Every day, millions of people rely on products or applications which contain our sustainable materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 40 years' experience, we are moving beyond the polymer into semi-finished and finished products which shape future performance for our customers and our markets, provide environmental and societal benefit for customers and drive value for our shareholders. Find out more at www.victrexplc.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEASLLESEAEFA
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

Notice of Full Year Results

12 hours, 32 minutes ago

Total Voting Rights

2 weeks, 6 days ago

Holding(s) in Company

on 10/05/2026

Total Voting Rights

on 09/30/2026

Capital Markets Event

on 09/24/2026

Holding(s) in Company

on 09/18/2026

4 min read